5433502022-07-012022-09-305433502022-09-305433502022-03-315433502022-04-012022-09-305433502022-07-012022-09-30in-bse-fin:OtherExpenses1Member5433502022-04-012022-09-30in-bse-fin:OtherExpenses1Member5433502022-07-012022-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15433502022-04-012022-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares543350VIJAYANOTLISTEDINE043W01024VIJAYA DIAGNOSTIC CENTRE LIMITEDEquity2022-04-012023-03-312022-11-102022-10-21INRLakhsHalf yearlySingle segmentDiagnostic Services2022-11-1012:10:002022-11-1013:35:00trueCash Flow IndirectNot applicable2022-07-012022-09-30UnauditedConsolidated120749300033043000124053600016653500000197418000487390001590310003561230009278460003126900000312690000678170001020100078018000023467200000002346720004780002351500002332520001420000233730000142000010206400012.2862.274002.2862.2741. The above consolidated financial results of Vijaya Diagnostic Centre Limited (formerly known as 'Vijaya Diagnostic Centre Private Limited') ("the Company") and its subsidiaries (the Company and its subsidiaries together referred to as "the Group") have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standards ("Ind AS") prescribed under Section 133 of the Companies Act, 2013 ('the Act') read with the relevant rules thereunder, other accounting principles generally accepted in India and in terms of Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. <BR> 2. The above consolidated financial results were reviewed by the audit committee and approved by the Board of Directors in their respective meetings held on 10 November 2022. The statutory auditors have carried out limited review of the above results for the quarter and year-to-date ended 30 September 2022. An unmodified report has been issued by them thereon. <BR> 3. The Board of Directors of the Company had proposed Final Dividend of Rs. 1 per equity share (Face value of Rs.1 each) for the year ended 31 March 2022. The same was approved by the shareholders in the Annual General Meeting of the Company held on 28 September 2022 and was paid on 12 October 2022. <BR> 4. The Group has one reportable segment (viz. Diagnostic Services) as per the requirements of Ind AS 108 "Operating Segments". <BR> 5. During the quarter ended 30 September 2022, the Company has issued 33,038 equity shares of face value of Rs. 1 each on exercise of employee stock options. <BR> 6. The Indian Parliament has approved the code on social security, 2020 ("Code") which, interalia, deals with employee benefits during employment and post employment. The code has been published in the Gazette of India. The effective date of the code is yet to be notified. The Group is in the process of evaluating the impact of the relevant provisions. <BR> 7. The results of the Group are available for investors at www.vijayadiagnostic.com, www.nseindia.com and www.bseindia.com2022-04-012022-09-30UnauditedConsolidated2251114000607360002311850000296863000003921780009639000030079000067572400017619450005499050000549905000139354000309000139663000041024200000004102420009550004111970004077520002490000408707000249000010206400013.9973.977003.9973.977Other expenses356123000Other expenses675724000479088200085528000053375000188030006024000004000000080638000810380008795200015134300052749450004518200084419400085823000190335000145804100003736300026157560000590380002719976000799492100010206400049013110005003375000157210005019096000002162385000216238500075914000004582000224288100011370002873630003389530006274530003814700031359000359850000732944000002975825000799492100088524000-241500011502000000029792000-210020007097600001209200003007900000238400000-1260800000462550003663000-866000000-44440003600004243750009742800000001130410000861239000000000002035000732306000-28873500000000000003546450000000002746100000-636900000000000108760000052090001500370000013300000-14450300079836000079836000110499000190335000Remeasurement of the defined benefit obligations638000638000Remeasurement of the defined benefit obligations1276000127600016000032100000